Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 116,456 | 71,183 | 52,334 | 42,865 | 33,560 |
| Cost of Goods | 42,849 | 20,204 | 15,325 | 13,191 | 11,581 |
| Gross Profit | 73,607 | 50,979 | 37,009 | 29,674 | 21,979 |
| Operating Expenses | 126,292 | 69,836 | 55,405 | 48,431 | 37,133 |
| Operating Income | -51,836 | -18,653 | -18,071 | -18,566 | -14,573 |
| Interest Expense | 5,344 | 14 | 628 | 3,101 | 2,158 |
| Other Income | -525 | 2,278 | -189 | -637 | -88 |
| Pre-tax Income | -57,705 | -16,389 | -18,888 | -22,304 | -16,819 |
| Income Tax | -4,875 | 137 | 136 | 166 | 83 |
| Net Income Continuous | -52,830 | -16,526 | -19,024 | -22,470 | -16,902 |
| Net Income | $-52,830 | $-16,526 | $-19,024 | $-22,470 | $-16,902 |
| EPS Basic Total Ops | -1.90 | -0.65 | -0.86 | -1.81 | -8.94 |
| EPS Basic Continuous Ops | -1.90 | -0.65 | -0.86 | -1.26 | -8.94 |
| EPS Diluted Total Ops | -1.90 | -0.65 | -0.86 | -1.81 | -8.94 |
| EPS Diluted Continuous Ops | -1.90 | -0.65 | -0.86 | -1.26 | -8.94 |
| EBITDA(a) | $-37,975 | $-16,102 | $-15,880 | $-16,974 | $-13,069 |